| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer
|
Mei, Dong
|
|
2019
|
9 |
5 |
p. 1061-1077
|
artikel
|
| 2 |
Cilastatin protects against imipenem-induced nephrotoxicity via inhibition of renal organic anion transporters (OATs)
|
Huo, Xiaokui
|
|
2019
|
9 |
5 |
p. 986-996
|
artikel
|
| 3 |
Direct interaction of DNMT inhibitors to PrPC suppresses pathogenic process of prion
|
Kim, Dae-Hwan
|
|
2019
|
9 |
5 |
p. 952-959
|
artikel
|
| 4 |
High degree of pharmacokinetic compatibility exists between the five-herb medicine XueBiJing and antibiotics comedicated in sepsis care
|
Li, Jian
|
|
2019
|
9 |
5 |
p. 1035-1049
|
artikel
|
| 5 |
Improvement in affinity and thermostability of a fully human antibody against interleukin-17A by yeast-display technology and CDR grafting
|
Sun, Wei
|
|
2019
|
9 |
5 |
p. 960-972
|
artikel
|
| 6 |
Inactivation of TFEB and NF-κB by marchantin M alleviates the chemotherapy-driven pro-tumorigenic senescent secretion
|
Niu, Huanmin
|
|
2019
|
9 |
5 |
p. 923-936
|
artikel
|
| 7 |
Injectable peptide hydrogel as intraperitoneal triptolide depot for the treatment of orthotopic hepatocellular carcinoma
|
Zhao, Xiyue
|
|
2019
|
9 |
5 |
p. 1050-1060
|
artikel
|
| 8 |
Kinsenoside attenuates osteoarthritis by repolarizing macrophages through inactivating NF-κB/MAPK signaling and protecting chondrocytes
|
Zhou, Feng
|
|
2019
|
9 |
5 |
p. 973-985
|
artikel
|
| 9 |
MCC1019, a selective inhibitor of the Polo-box domain of Polo-like kinase 1 as novel, potent anticancer candidate
|
Abdelfatah, Sara
|
|
2019
|
9 |
5 |
p. 1021-1034
|
artikel
|
| 10 |
Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides/proteins
|
Han, Ying
|
|
2019
|
9 |
5 |
p. 902-922
|
artikel
|
| 11 |
New era of drug innovation in China
|
Ye, Xuan
|
|
2019
|
9 |
5 |
p. 1084-1085
|
artikel
|
| 12 |
Orthogonal assays for the identification of inhibitors of the single-stranded nucleic acid binding protein YB-1
|
Trevarton, AlexanderJ.
|
|
2019
|
9 |
5 |
p. 997-1007
|
artikel
|
| 13 |
Structural simplification: an efficient strategy in lead optimization
|
Wang, Shengzheng
|
|
2019
|
9 |
5 |
p. 880-901
|
artikel
|
| 14 |
Synergistic antitumor activity of artesunate and HDAC inhibitors through elevating heme synthesis via synergistic upregulation of ALAS1 expression
|
Chen, Cai-Ping
|
|
2019
|
9 |
5 |
p. 937-951
|
artikel
|
| 15 |
Table of Contents
|
|
|
2019
|
9 |
5 |
p. iii-viii
|
artikel
|
| 16 |
Targeting the untargetable KRAS in cancer therapy
|
Liu, Pingyu
|
|
2019
|
9 |
5 |
p. 871-879
|
artikel
|
| 17 |
The dimerization of Δ 9-tetrahydrocannabinolic acid A (THCA-A)
|
Cuadari, Arben
|
|
2019
|
9 |
5 |
p. 1078-1083
|
artikel
|
| 18 |
Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2
|
Chen, Lu
|
|
2019
|
9 |
5 |
p. 1008-1020
|
artikel
|
Tijdschrift beschrijving